Societe de Promotion Pharmaceutique du Maghreb S.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was MAD 844.21 million compared to MAD 746.77 million a year ago. Net income was MAD 56.9 million compared to MAD 75.28 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
934 MAD | -.--% | -.--% | -6.60% |
1st Jan change | Capi. | |
---|---|---|
-6.60% | 93.7M | |
+20.50% | 43.77B | |
+28.10% | 22.83B | |
+20.25% | 15.56B | |
+19.14% | 14.34B | |
+56.06% | 12.96B | |
-0.05% | 6.79B | |
-12.24% | 6.41B | |
-8.87% | 5.73B | |
+14.65% | 5.69B |
- Stock Market
- Equities
- PRO Stock
- News Societe de Promotion Pharmaceutique du Maghreb S.A.
- Societe de Promotion Pharmaceutique du Maghreb S.A. Reports Earnings Results for the Full Year Ended December 31, 2023